NDVR »

Supernus Pharmaceuticals shares owned by NDVR

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by NDVR from 13F filings

Historical chart of NDVR investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by NDVR consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by NDVR

Quarter filed Position value Share count Share price at filing
2025-09-30 $207k 4.3k 47.79

More positions owned by NDVR

Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Hubspot (HUBS)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Amazon (AMZN)
Microsoft Corporation (MSFT)
World Gold Tr Spdr Gld Minis (GLDM)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Wal-Mart Stores (WMT)

View all positions for NDVR

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Dimensional Fund Advisors
Armistice Capital
Macquarie Group
State Street Corporation
Point72 Asset Management
Renaissance Technologies
Citadel Advisors
Geode Capital Management
Stephens Investment Management Group
Loomis, Sayles and
Woodline Partners
Goldman Sachs Group
Jennifer Ranahan

View all funds holding Supernus Pharmaceuticals